In the last decades, the modulation studies of GLYI expression/activity have received growing attention in mammalian systems for the key role of this enzyme in obesity, diabetes, cardiovascular diseases, chronic renal failure, cancer, neurological disorders (Rabbani et al., 2016). This evidence concerns the gene GLO1 and nervous system disorder.